Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Wednesday, June 15, 2022
Breakthrough Cooperation of Legend Capital's Cross-border Portfolio Companies: Innovent and Etana Jointly Announce the Approval of Bevagen by the BPOM
Thursday, June 9, 2022
Legend Capital Portfolio: Japan's No.1 VTuber Operator ANYCOLOR Lists on the Tokyo Stock Exchange
Friday, May 27, 2022
Legend Capital's Portfolio Company Feima Robotics Assists China's 38th Antarctic Expedition with a Series of Civilian UAV Products
Wednesday, April 27, 2022
Legend Capital's Portfolio Company Xbiome Acquires Clinical-Stage Program Targeting Ulcerative Colitis
Tuesday, April 26, 2022
Legend Capital Portfolio: Korean Medical AI Company Lunit to List on KOSDAQ in 2Q2022
Sunday, April 24, 2022
Legend Capital's Co-founded Company Innostellar Biotherapeutics: IRD Gene Therapy Product was Approved for Clinical Trial in China
Thursday, April 7, 2022
Legend Capital's Portfolio Company Recbio Lists on HKEX Successfully
Thursday, March 3, 2022
Inceptio Technology Completes Financing of US$188 Million, Jointly Led by Legend Capital
Wednesday, March 2, 2022
Inceptio Technology Completes Financing of US$188 Million, Jointly Led by Legend Capital
Thursday, December 16, 2021
Legend Capital's Portfolio Company SF Intra-city Successfully Listed on HKEx

Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: